Biotech Values

[Double_Bagel]

Dumb as a Rock "ModernRock" shorts SRPT on good news for SRPT:

https://twitter.com/search?q=%24srpt&src=typd&f=realtime

$SRPT took idea from @BioRunUp shorted 13.91 $SRPT - FDA panelist confirms conflict of interest http://bit.ly/1DfEOLd

In a follow up tweet he says:

SRPT i did no DD just saw the news posted and took a chance. headline seems NOT GOOD lol

http://www.bizjournals.com/boston/blog/bioflash/2015/03/fda-panelist-confirms-conflict-of-interest.html?ana=twt

FDA panelist confirms conflict of interest following Sarepta drug discussions

A key member of a recently organized Food & Drug Administration panel told the Boston Business Journal he failed to disclose a financial conflict of interest prior to participating in formal discussions that could affect the approval of several drugs to treat Duchenne muscular dystrophy.

Among the companies potentially affected by the matter is Sarepta Therapeutics (Nasdaq: SRPT), the methods of which drew particular scrutiny from the FDA panel in question during the March 20 workshop titled “ Measuring Dystrophin in Dystrophinopathy Patients and Interpreting the Data. The event was held at the FDA's headquarters in Silver Spring, Md., with the aim of gathering expert opinions on how best to measure a protein called dystrophin.

Of course, a winning strategy with SRPT is to short it on any kind of news

I thought that this was information that everybody knew. The FDA should have known it and should have excluded Hoffman in the first place. Kind of like having a guy who was paid by GSK run the adcom panel for Dynavax's Heplisav vaccine.

No, there is nothing crooked in the FDA!